Home Page - AR-BIC Conference

AR-BIC 11th Annual CONFERENCE

RESCHEDULED

Monday, November 3rd- Tuesday November 4th

Embassy Suites in Rogers. AR

Check Back for More Information

Agenda

registration

AR-BIC 2024 Proceedings

Ayako Suzuki

Ayako Suzuki, MD, PhD

Associate Professor of Gastroenterology, Duke University
Presentation title: EHR Research and In Silico Approaches to Advance Precision Medicine and Enhance Drug Safety

Viswanath Devanarayan

Viswanath Devanarayan, PhD

Head of Clinical Data Science, Eisai Inc. Adjunct Professor, University of Illinois Chicago
Presentation title: AI in FDA: Opportunities and Challenges

Tucker Patterson

Tucker Patterson, PhD

Director, FDA/National Center for Toxicological Research
Presentation title: AI in FDA: Opportunities and Challenges

Tucker Patterson

May Dongmei Wang, PhD

Wallace H. Coulter Distinguished Faculty Fellow
Professor of BME, ECE, CSE, Georgia Institute of Technology and Emory University

Cash award competition & abstract deadline: January 10, 2025 (instructions)

Highlights:

4 plenary presentations to overview transformative technologies in academia, government, and industry

3 workshops to improve your capability of using generative AI in research

6 breakout sessions to share specific experiences with transformative technologies

Cash awards for student & postdoc poster presentations ($500/$300/$200 for 1^st/2^nd/3^rd place for each category)

Opportunity to publish in the conference proceedings

AR-BIC

ORGANIZED BY THE ARKANSAS BIOINFORMATICS CONSORTIUM

We are an Arkansas-centric community that facilitates communication and collaboration to leverage Arkansas expertise and resources in data sciences and bioinformatics. Established in 2014, AR-BIC began to fulfill this mission by hosting annual conferences. The themes of the meetings explored bioinformatics applications in precision medicine, agriculture, data sciences, and artificial intelligence.

learn more

This website is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award [FAIN] totaling $15,000 with 100 percent funded by FDA/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.